Rna Interference (RNAi) is a natural cellular mechanism that regulates gene expression by silencing specific target genes through the degradation of messenger RNA (mRNA). This process plays a fundamental role in controlling various biological processes, including development, immune response, and defense against viral infections. The discovery of RNAi has paved the way for its application as a powerful tool in molecular biology and therapeutic interventions. Small RNA molecules, such as small interfering RNA (siRNA) and microRNA (miRNA), are key players in RNA interference. Synthetic siRNAs, designed to match the sequence of a target gene, can be introduced into cells to trigger the degradation of the corresponding mRNA, effectively inhibiting gene expression. Similarly, endogenous miRNAs regulate gene expression by binding to target mRNAs, leading to translational repression or mRNA degradation. RNAi technology has become a widely used experimental tool in laboratories, enabling researchers to selectively silence genes of interest to study their function. In the realm of therapeutics, RNAi holds immense potential for treating various diseases, including genetic disorders, viral infections, and certain types of cancer. Efforts are underway to develop RNAi-based drugs that can be delivered to target cells, offering a precise and customizable approach to gene therapy. Challenges in harnessing RNAi for therapeutic purposes include effective delivery of RNA molecules to target tissues, off-target effects, and potential immune responses. Researchers are actively exploring innovative delivery systems, such as lipid nanoparticles and viral vectors, to overcome these obstacles.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States